These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33587255)

  • 21. [On the treatment of thyroid cancer and its metastases with radioiodine 131].
    CLOSUIT M; LAPP R; LERCH P
    Helv Med Acta; 1951 Oct; 18(4-5):469-74. PubMed ID: 14873181
    [No Abstract]   [Full Text] [Related]  

  • 22. Lenvatinib - A multikinase inhibitor for radioiodine-refractory differentiated thyroid cancer.
    Hewett Y; Ghimire S; Farooqi B; Shah BK
    J Oncol Pharm Pract; 2018 Jan; 24(1):28-32. PubMed ID: 27856921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted therapy in radioiodine refractory thyroid cancer.
    Pacini F; Brilli L; Marchisotta S
    Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):520-5. PubMed ID: 19910905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herbal Active Ingredients: An Emerging Potential for the Prevention and Treatment of Papillary Thyroid Carcinoma.
    Yang Y; Chen Q; Yu WY; Zhang HH; Zhong YS; Zhang SZ; Wang JF; Yu CH
    Biomed Res Int; 2020; 2020():1340153. PubMed ID: 32090065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioiodine treatment for malignant thyroid disease.
    Berg G
    Acta Oncol; 2006; 45(8):1041-5. PubMed ID: 17118836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of radioactive iodine for adjuvant therapy and treatment of metastases.
    Jonklaas J
    J Natl Compr Canc Netw; 2007 Jul; 5(6):631-40. PubMed ID: 17623614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioiodine in the treatment of thyroid disease.
    RAWSON RW
    Surg Gynecol Obstet; 1953 Jan; 96(1):118-20. PubMed ID: 13015359
    [No Abstract]   [Full Text] [Related]  

  • 28. Radioiodine in the treatment of metastatic thyroid carcinoma.
    SEIDLIN SM
    Med Clin North Am; 1952 May; 36(3):663-80. PubMed ID: 14928848
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical uses of recombinant human thyrotropin.
    Gourgiotis L; Skarulis MC
    Expert Opin Pharmacother; 2004 Dec; 5(12):2503-14. PubMed ID: 15571468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing radioiodine refractory thyroid cancer: the role of dosimetry and redifferentiation on subsequent I-131 therapy.
    Dotinga M; Vriens D; van Velden F; Heijmen L; Nagarajah J; Hicks R; Kapiteijn E; de Geus-Oei LF
    Q J Nucl Med Mol Imaging; 2020 Sep; 64(3):250-264. PubMed ID: 32744039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation for radioiodine therapy: how to increase therapeutic efficacy and accelerate unbound radioiodine excretion.
    Matović M
    Vojnosanit Pregl; 2013 May; 70(5):504-10. PubMed ID: 23789291
    [No Abstract]   [Full Text] [Related]  

  • 32. New approaches in the management of radioiodine-refractory thyroid cancer: the molecular targeted therapy era.
    Capdevila J; Argiles G; Rodriguez-Frexinos V; Nuñez I; Tabernero J
    Discov Med; 2010 Feb; 9(45):153-62. PubMed ID: 20193642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Radioactive iodine therapy of metastasizing colloid struma; radioiodine therapy of carcinoma of the thyroid gland].
    PAOLINO W; ZAMBELLI E
    Minerva Med; 1952 Aug; 43(63-64):198-205. PubMed ID: 13012927
    [No Abstract]   [Full Text] [Related]  

  • 34. [Radioiodine therapy of thyroid carcinoma].
    EICHLER O; HESS H; LINDER F; SCHMEISER K
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1951; 269(1):19-36. PubMed ID: 14869113
    [No Abstract]   [Full Text] [Related]  

  • 35. Radioiodine therapy for thyroid cancer in the era of risk stratification and alternative targeted therapies.
    Pryma DA; Mandel SJ
    J Nucl Med; 2014 Sep; 55(9):1485-91. PubMed ID: 25134528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of thiouracil in the treatment of metastatic carcinoma of the thyroid with radioiodine.
    RALL JE; MILLER WN; FOSTER CG; PEACOCK WC; RAWSON RW
    J Clin Endocrinol Metab; 1951 Nov; 11(11):1273-80. PubMed ID: 14880607
    [No Abstract]   [Full Text] [Related]  

  • 37. [Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences].
    Hasse-Lazar K; Handkiewicz-Junak D; Roskosz J; Szpak-Ulczok S; Krajewska J; Jurecka-Lubieniecka B; Jarzab B
    Endokrynol Pol; 2006; 57(4):445-50. PubMed ID: 17006851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of radioiodine to induce thyroid cancer in the rat.
    FIELD JB; McCAMMON CJ; VALENTINE RJ; BERNICK S; ORR C; STARR P
    Cancer Res; 1959 Sep; 19():870-3. PubMed ID: 13822678
    [No Abstract]   [Full Text] [Related]  

  • 39. [Lithium as an adjuvant in the radioiodine therapy of thyroid cancer].
    Schraube P; Kimmig B; zum Winkel K
    Nuklearmedizin; 1984 Jun; 23(3):151-4. PubMed ID: 6435095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limitations and indications in the treatment of cancer of the thyroid with radioactive iodine.
    RAWSON RW; RALL JE; PEACOCK W
    J Clin Endocrinol Metab; 1951 Oct; 11(10):1128-42. PubMed ID: 14873783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.